Double‐negative T cells: Setting the stage for disease control or progression is a research paper published in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 93 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Foundation for the National Institutes of Health
Grant: 1R01AI138230‐01
NIAID NIH HHS
Grant: R01 AI138230
NIH HHS
Grant: 1R01AI138230-01
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Fundação de Amparo à Pesquisa do Estado de Minas Gerais
MeSH Terms
Keywords
Additional file 1 of Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial
Additional file 1 of Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial